Cargando…

Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up

The synthesis of Mobil Composition of Matter 41 (MCM-41) mesoporous silica nanoparticles (MSNs) of controlled sizes and porous structure has been performed at laboratory and pilot plant scales. Firstly, the effects of the main operating conditions (TEOS –Tetraethyl ortosilicate– addition rate, nanop...

Descripción completa

Detalles Bibliográficos
Autores principales: Castillo, Rafael R., de la Torre, Lorena, García-Ochoa, Félix, Ladero, Miguel, Vallet-Regí, María
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662541/
https://www.ncbi.nlm.nih.gov/pubmed/33114330
http://dx.doi.org/10.3390/ijms21217899
_version_ 1783609419909562368
author Castillo, Rafael R.
de la Torre, Lorena
García-Ochoa, Félix
Ladero, Miguel
Vallet-Regí, María
author_facet Castillo, Rafael R.
de la Torre, Lorena
García-Ochoa, Félix
Ladero, Miguel
Vallet-Regí, María
author_sort Castillo, Rafael R.
collection PubMed
description The synthesis of Mobil Composition of Matter 41 (MCM-41) mesoporous silica nanoparticles (MSNs) of controlled sizes and porous structure has been performed at laboratory and pilot plant scales. Firstly, the effects of the main operating conditions (TEOS –Tetraethyl ortosilicate– addition rate, nanoparticle maturation time, temperature, and CTAB –Cetrimonium bromide– concentration) on the synthesis at laboratory scale (1 L round-bottom flask) were studied via a Taguchi experimental design. Subsequently, a profound one-by-one study of operating conditions was permitted to upscale the process without significant particle enlargement and pore deformation. To achieve this, the temperature was set to 60 °C and the CTAB to TEOS molar ratio to 8. The final runs were performed at pilot plant scale (5 L cylindrical reactor with temperature and stirring speed control) to analyze stirring speed, type of impeller, TEOS addition rate, and nanoparticle maturation time effects, confirming results at laboratory scale. Despite slight variations on the morphology of the nanoparticles, this methodology provided MSNs with adequate sizes and porosities for biomedical applications, regardless of the reactor/scale. The process was shown to be robust and reproducible using mild synthesis conditions (2 mL⋅min(−1) TEOS addition rate, 400 rpm stirred by a Rushton turbine, 60 min maturation time, 60 °C, 2 g⋅L(−1) CTAB, molar ratio TEOS/CTAB = 8), providing ca. 13 g of prismatic short mesoporous 100–200 nm nanorods with non-connected 3 nm parallel mesopores.
format Online
Article
Text
id pubmed-7662541
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-76625412020-11-14 Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up Castillo, Rafael R. de la Torre, Lorena García-Ochoa, Félix Ladero, Miguel Vallet-Regí, María Int J Mol Sci Article The synthesis of Mobil Composition of Matter 41 (MCM-41) mesoporous silica nanoparticles (MSNs) of controlled sizes and porous structure has been performed at laboratory and pilot plant scales. Firstly, the effects of the main operating conditions (TEOS –Tetraethyl ortosilicate– addition rate, nanoparticle maturation time, temperature, and CTAB –Cetrimonium bromide– concentration) on the synthesis at laboratory scale (1 L round-bottom flask) were studied via a Taguchi experimental design. Subsequently, a profound one-by-one study of operating conditions was permitted to upscale the process without significant particle enlargement and pore deformation. To achieve this, the temperature was set to 60 °C and the CTAB to TEOS molar ratio to 8. The final runs were performed at pilot plant scale (5 L cylindrical reactor with temperature and stirring speed control) to analyze stirring speed, type of impeller, TEOS addition rate, and nanoparticle maturation time effects, confirming results at laboratory scale. Despite slight variations on the morphology of the nanoparticles, this methodology provided MSNs with adequate sizes and porosities for biomedical applications, regardless of the reactor/scale. The process was shown to be robust and reproducible using mild synthesis conditions (2 mL⋅min(−1) TEOS addition rate, 400 rpm stirred by a Rushton turbine, 60 min maturation time, 60 °C, 2 g⋅L(−1) CTAB, molar ratio TEOS/CTAB = 8), providing ca. 13 g of prismatic short mesoporous 100–200 nm nanorods with non-connected 3 nm parallel mesopores. MDPI 2020-10-24 /pmc/articles/PMC7662541/ /pubmed/33114330 http://dx.doi.org/10.3390/ijms21217899 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Castillo, Rafael R.
de la Torre, Lorena
García-Ochoa, Félix
Ladero, Miguel
Vallet-Regí, María
Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up
title Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up
title_full Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up
title_fullStr Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up
title_full_unstemmed Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up
title_short Production of MCM-41 Nanoparticles with Control of Particle Size and Structural Properties: Optimizing Operational Conditions during Scale-Up
title_sort production of mcm-41 nanoparticles with control of particle size and structural properties: optimizing operational conditions during scale-up
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7662541/
https://www.ncbi.nlm.nih.gov/pubmed/33114330
http://dx.doi.org/10.3390/ijms21217899
work_keys_str_mv AT castillorafaelr productionofmcm41nanoparticleswithcontrolofparticlesizeandstructuralpropertiesoptimizingoperationalconditionsduringscaleup
AT delatorrelorena productionofmcm41nanoparticleswithcontrolofparticlesizeandstructuralpropertiesoptimizingoperationalconditionsduringscaleup
AT garciaochoafelix productionofmcm41nanoparticleswithcontrolofparticlesizeandstructuralpropertiesoptimizingoperationalconditionsduringscaleup
AT laderomiguel productionofmcm41nanoparticleswithcontrolofparticlesizeandstructuralpropertiesoptimizingoperationalconditionsduringscaleup
AT valletregimaria productionofmcm41nanoparticleswithcontrolofparticlesizeandstructuralpropertiesoptimizingoperationalconditionsduringscaleup